In this issue of Gastroenterology Clinics, guest editor Dr. R. Balfour Sartor brings his considerable expertise to the topic of The Microbiome. Research on the gut microbiome has revealed significant implications for gastrointestinal diseases, with clinical trials resulting in potential treatments for the management of GI diseases and their associated risk factors. Further, understanding the gut microbiome’s role in gastrointestinal health opens avenues for targeted interventions and personalized approaches to disease management. This issue presents the latest research, treatments, and clinical approaches in this key area of gastroenterology.
Contains 13 relevant, practice-oriented topics, including the role of intestinal microbiome in potentiating inflammation and predicting outcomes in alcoholic hepatitis; intestinal microbial modulation of therapeutic efficacy and complications of cancer immunotherapy; beyond fecal microbial transplant: next generation approaches to manipulating dysbiotic microbiota to treat IBD; dysbiotic microbiota in necrotizing enterocolitis; microbial approaches to treat and prevent hepatic encephalopathy; and more Provides in-depth clinical reviews on the microbiome, offering actionable insights for clinical practice Presents the latest information on this timely, focused topic under the leadership of experienced editors in the field. Authors synthesize and distill the latest research and practice guidelines to create clinically significant, topic-based reviews
Edited by:
R. Balfour Sartor
Imprint: Churchill Livingstone
Country of Publication: United Kingdom
Dimensions:
Height: 229mm,
Width: 152mm,
Weight: 450g
ISBN: 9780443314544
ISBN 10: 0443314543
Series: The Clinics: Internal Medicine
Pages: 240
Publication Date: 23 May 2025
Audience:
Professional and scholarly
,
Undergraduate
Format: Hardback
Publisher's Status: Active
Current Approaches to Treat and Prevent Recurrence of Clostridioides difficile Optimizing Therapeutic Potential of Fecal Transplant in Inflammatory Bowel Disease Intestinal Microbiome Modulation of Therapeutic Efficacy of Cancer Immunotherapy Personalized Dietary Approaches to Optimizing Intestinal Microbial Health and Homeostasis Beyond Random Fecal Microbial Transplants: Next Generation Personalized Approaches to Normalize Dysbiotic Microbiota for Treating IBD Microbial Influences on Irritable Bowel Syndrome Understanding Microbial Mediation of the Brain-Gut Axis Phase IV Metabolism: Gut Microbial Metabolism of Common Gastrointestinal Drugs Current Understanding of Optimal Prevention of Helicobacter pylori--Induced Cancer Dysbiotic Microbiota in Necrotizing Enterocolitis: Insights into Pathogenesis, Treatment, and Prevention Microbial Approaches to Treat and Prevent Hepatic Encephalopathy Role of Intestinal Microbiome in Potentiating Inflammation and Predicting Outcomes in Alcohol-Associated Cirrhosis Optimal Approaches to Treating and Preventing Acute and Chronic Pouchitis by Altering Microbial Profiles
